Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Colimesta 3 MIU Injection

Prescription Icon
Prescription Required

Marketer

Alvista Biosciences Pvt Ltd

Salt Composition

Colistimethate Sodium (3000000IU)

Overview Colimesta 3 MIU Injection

Colimesta 3 MIU Injection, a potent antibacterial agent, combats serious systemic bacterial infections. Primarily administered to critically ill hospitalized individuals, this injectable antibiotic requires strict medical oversight. Self-administration is strictly prohibited. Dosage and treatment length are determined by your physician, tailored to the infection's severity and nature. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Potential side effects, such as nausea, speech impairment, lightheadedness, vertigo, pyrexia, dermatological reactions, and tingling sensations, are generally transient, resolving as the body acclimates. Persistent or bothersome effects warrant immediate medical attention. Prior to commencing treatment, disclose any antibiotic allergies, renal or hepatic impairments to your doctor. Pregnant or lactating women should seek medical counsel before use. Regular blood tests may be conducted to monitor renal function and drug levels.

Primary Ingredients of Colimesta 3 MIU Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Colimesta 3 MIU Injection

Life-threatening bacterial infections

Major Benefits of Colimesta 3 MIU Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Colimesta 3 MIU Injection:

  • Slurred speech
  • Upset stomach
  • Dizziness
  • Gastrointestinal disturbance
  • Paresthesia (tingling or pricking sensation)
  • Vertigo
  • Rash
  • Fever
  • Generalized itching
  • Red spots or bumps
  • Increased blood urea nitrogen
  • Increased creatinine level in blood
  • Decreased creatinine clearance
  • Respiratory distress
  • Apnea (absence of breathing)
  • Renal toxicity
  • Decreased urinary volume

How to use Colimesta 3 MIU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Colimesta 3 MIU Injection works:

Colimesta 3 MIU, administered via injection, is a bactericidal antibiotic that disrupts bacterial cell membranes.

SAFETY ADVICE

AlcoholAlcoholSAFE

Colimesta 3 MIU Injection may be used concurrently with alcohol without adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Colimesta 3 MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Colimesta 3 MIU Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Administering Colimesta 3 MIU Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects manifest.

KidneyKidneyCAUTION

Caution is advised when administering Colimesta 3 MIU Injection to individuals with impaired renal function. Dosage modification of Colimesta 3 MIU Injection might be necessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Colimesta 3 MIU Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Colimesta 3 MIU Injection :

NA

Facts to Know About Colimesta 3 MIU Injection

LabelValue
Type of Compound Short chains of amino acids.
Potential for Dependence None.
Type of Treatment Antimicrobial agents

FAQs on Colimesta 3 MIU Injection

Prior to administering Colimesta 3 MIU Injection, inform your physician of any pre-existing or past kidney or lung conditions, including asthma. Disclose all other medications you are currently using, as interactions with Colimesta 3 MIU Injection are possible.
Colimesta 3 MIU Injection must be given only by a qualified healthcare provider and should never be self-injected. Dosage is determined by your physician based on your specific medical needs. Adhere strictly to your doctor's prescribing instructions for optimal treatment outcomes with Colimesta 3 MIU Injection.
Administering Colimesta 3 MIU Injection is contraindicated for individuals with a known hypersensitivity to Colimesta 3 MIU Injection or its constituents. Patients unsure of any allergies or using Colimesta 3 MIU Injection for the initial time should seek medical advice.
Insufficient data exists to definitively determine the safety of Colimesta 3 MIU Injection during pregnancy. Therefore, pregnant individuals or those planning pregnancy should seek medical advice before using this injection. Its administration should be solely as directed by a physician.
Administering Colimesta 3 MIU Injection is safe when adhering to the prescribed dosage and treatment schedule. Strictly follow the recommended regimen, avoiding missed injections. Closely observe your physician's guidance and report any adverse reactions.
Prior to administering Colimesta 3 MIU Injection, inform your physician of any pre-existing or past kidney or lung conditions, including asthma. Disclose all concurrent medications, as interactions with Colimesta 3 MIU Injection are possible.
Colimesta 3 MIU Injection requires administration by a qualified healthcare provider; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. Adhere closely to your doctor's prescribed regimen to optimize treatment outcomes with Colimesta 3 MIU Injection.
Patients with a known allergy to Colimesta 3 MIU Injection or its constituents should refrain from its administration. First-time users or those uncertain about potential allergic reactions should seek medical advice before using Colimesta 3 MIU Injection.
Insufficient data exists to definitively establish the safety of Colimesta 3 MIU Injection during pregnancy. Therefore, pregnant individuals or those intending to become pregnant should seek medical advice prior to its administration. Use is only advisable under explicit physician guidance.
Administering Colimesta 3 MIU Injection is safe when used according to your physician's prescribed dosage and timeframe. Strictly adhere to the recommended regimen, avoiding missed injections. Closely observe your doctor's guidance and report any adverse reactions.
Colimesta 3 MIU Injection
2,208
MRP 2,690
17% off